↓ Skip to main content

Melatonin increases the survival time of animals with untreated mammary tumours: Neuroendocrine stabilization

Overview of attention for article published in Molecular and Cellular Biochemistry, October 2005
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
16 Mendeley
Title
Melatonin increases the survival time of animals with untreated mammary tumours: Neuroendocrine stabilization
Published in
Molecular and Cellular Biochemistry, October 2005
DOI 10.1007/s11010-005-7755-9
Pubmed ID
Authors

M. C. Saez, C. Barriga, J. J. Garcia, A. B. Rodriguez, J. Masot, E. Duran, E. Ortega

Abstract

The aim of this study was to evaluate the therapeutic effect of melatonin, the main hormone of the pineal gland, on rats with advanced and untreated mammary tumours. Mammary tumours were chemically induced in Sprague-Dawley rats with the carcinogen 9,10-dimethyl-1,2-bezanthracene (DMBA). After the appearance of tumours the effect of melatonin (5 mg/ml per rat per day) was then evaluated on the survival time, tumour multiplicity, and tumour volume until the death of the animals. In addition, the variations in prolactin, noradrenaline and adrenaline concentrations, and in the percentage of NK cells were evaluated after one month of the treatment with melatonin. Daily administration of melatonin increased significantly the survival time of tumour-bearing animals (p<0.05 with respect to the control non-melatonin-receiving rats). The increased survival time did not correlate, however, with changes in either tumour multiplicity or tumour growth rate. Animals with mammary tumours exhibited an increase (p<0.05 with respect to healthy animals) in prolactin and catecholamine concentrations. The administration of melatonin stabilized the hormone levels, returning them to those in the basal-healthy animals. Rats with mammary tumours also presented lower percentages of NK cells, which were not increased by the administration of melatonin. The results strongly suggest that melatonin per se is beneficial during advanced breast cancer. It increases survival time, maybe by improving the homeostatic and neuroendocrine equilibrium which is imbalanced during advanced breast cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 6%
Unknown 15 94%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 3 19%
Student > Bachelor 2 13%
Student > Postgraduate 2 13%
Researcher 2 13%
Student > Master 1 6%
Other 3 19%
Unknown 3 19%
Readers by discipline Count As %
Medicine and Dentistry 6 38%
Agricultural and Biological Sciences 4 25%
Neuroscience 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Unknown 4 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2014.
All research outputs
#17,689,426
of 22,711,242 outputs
Outputs from Molecular and Cellular Biochemistry
#1,471
of 2,292 outputs
Outputs of similar age
#55,481
of 59,133 outputs
Outputs of similar age from Molecular and Cellular Biochemistry
#13
of 16 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,292 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,133 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.